Madrigal Pharma (MDGL) option IV into FDA approves Madrigal Pharmaceuticals' Rezdiffra

Go back to Madrigal Pharma (MDGL) option IV into FDA approves Madrigal Pharmaceuticals' Rezdiffra
(NASDAQ: MDGL) Delayed: 508.33 +2.58 (0.51%)
Previous Close $505.75    52 Week High $18.24 
Open $513.23    52 Week Low $6.60 
Day High $515.00    P/E N/A 
Day Low $505.91    EPS $0.00 
Volume 29,531